BRUCE L A CARTER
CIK 1225503 · CEO & Chairman of the Board · last filed 2026-03-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.15M
Companies
7
Total Filings
66
Lifetime Open-Market Net
-$6.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTA | Director | 807 | $11.90 | $9.6K | -$1.26M | 16 | 2026-03-13 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 6,808 | $58.70 | $399.6K | -$3.95M | 20 | 2024-01-23 |
| XNCR | Director | 48,880 | $12.33 | $602.7K | -$1.01M | 7 | 2017-06-16 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 0 | $8.16 | $0 | -$353.2K | 5 | 2015-06-26 |
| QLTI | Director | 20,000 | $26.82 | $536.4K | $41.4K | 6 | 2011-05-27 |
| ZYMOGENETICS INC (ZGEN) Delisted | Director | 115,399 | $12.01 | $1.39M | $298.3K | 10 | 2010-10-12 |
| RENOVIS INC (RNVS) Delisted | Director | — | — | — | $0 | 1 | 2007-01-30 |
Recent Filings · Page 5 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-15 | XNCR | Mixed | — | -$186.2K | EDGAR |
| 2015-06-11 | XNCR | Grant (A) | — | $0 | EDGAR |
| 2015-04-14 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$257.6K | EDGAR |
| 2015-02-20 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2013-12-06 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2013-06-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-11-08 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-27 | QLTI | Grant (A) | — | $0 | EDGAR |
| 2010-10-12 | ZYMOGENETICS INC (ZGEN) Delisted | U | −468,750 | -$4.57M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.